Fig. 1
From: Genetic sex validation for sample tracking in next-generation sequencing clinical testing
eMERGE sample processing workflow. Steps indicating where aliquots of DNA are taken from samples that are presented to the Clinical DNA Sequencing Laboratory for accession, to test via the Fluidigm 96-SNP panel assay. Data from the Fluidigm 96-SNP panel assay are compared with DNA sequence data from the DNA sequencing pipeline as a quality control step, ahead of the Automated Clinical Reporting step